Literature DB >> 21310615

Four and a half LIM protein 1 gene mutations cause four distinct human myopathies: a comprehensive review of the clinical, histological and pathological features.

Belinda S Cowling1, Denny L Cottle, Brendan R Wilding, Colleen E D'Arcy, Christina A Mitchell, Meagan J McGrath.   

Abstract

Mutations in the four and a half LIM protein 1 (FHL1) gene were recently identified as the cause of four distinct skeletal muscle diseases. Since the initial report outlining the first fhl1 mutation in 2008, over 25 different mutations have been identified in patients with reducing body myopathy, X-linked myopathy characterized by postural muscle atrophy, scapuloperoneal myopathy and Emery-Dreifuss muscular dystrophy. Reducing body myopathy was first described four decades ago, its underlying genetic cause was unknown until the discovery of fhl1 mutations. X-linked myopathy characterized by postural muscle atrophy is a novel disease where fhl1 mutations are the only cause. This review will profile each of the FHL1, with a comprehensive analysis of mutations, a comparison of the clinical and histopathological features and will present several hypotheses for the possible disease mechanism(s).
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21310615     DOI: 10.1016/j.nmd.2011.01.001

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  31 in total

Review 1.  Myofibrillar myopathies: new developments.

Authors:  Montse Olivé; Rudolf A Kley; Lev G Goldfarb
Journal:  Curr Opin Neurol       Date:  2013-10       Impact factor: 5.710

2.  199th ENMC international workshop: FHL1 related myopathies, June 7-9, 2013, Naarden, The Netherlands.

Authors:  Anne T Bertrand; Carsten G Bönnemann; Gisèle Bonne
Journal:  Neuromuscul Disord       Date:  2014-02-14       Impact factor: 4.296

Review 3.  Four and a half LIM domain protein signaling and cardiomyopathy.

Authors:  Yan Liang; William H Bradford; Jing Zhang; Farah Sheikh
Journal:  Biophys Rev       Date:  2018-06-20

4.  Fhl1 W122S causes loss of protein function and late-onset mild myopathy.

Authors:  Valentina Emmanuele; Akatsuki Kubota; Beatriz Garcia-Diaz; Caterina Garone; Hasan O Akman; Daniel Sánchez-Gutiérrez; Luis M Escudero; Shingo Kariya; Shunichi Homma; Kurenai Tanji; Catarina M Quinzii; Michio Hirano
Journal:  Hum Mol Genet       Date:  2014-09-30       Impact factor: 6.150

5.  Phenotypic heterogeneity in British patients with a founder mutation in the FHL1 gene.

Authors:  Anna Sarkozy; Christian Windpassinger; Judith Hudson; Charlotte F Dougan; Bryan Lecky; David Hilton-Jones; Michelle Eagle; Richard Charlton; Rita Barresi; Hanns Lochmüller; Kate Bushby; Volker Straub
Journal:  Eur J Hum Genet       Date:  2011-06-01       Impact factor: 4.246

6.  A study of FHL1, BAG3, MATR3, PTRF and TCAP in Australian muscular dystrophy patients.

Authors:  Leigh B Waddell; Jenny Tran; Xi F Zheng; Carsten G Bönnemann; Ying Hu; Frances J Evesson; Monkol Lek; Susan Arbuckle; Min-Xia Wang; Robert L Smith; Kathryn N North; Nigel F Clarke
Journal:  Neuromuscul Disord       Date:  2011-06-17       Impact factor: 4.296

Review 7.  Muscle MRI in pediatrics: clinical, pathological and genetic correlation.

Authors:  Claudia P Cejas; Maria M Serra; David F Gonzalez Galvez; Eliana A Cavassa; Ana L Taratuto; Gabriel A Vazquez; Mario E L Massaro; Angeles V Schteinschneider
Journal:  Pediatr Radiol       Date:  2017-01-19

8.  Dysregulation of FHL1 spliceforms due to an indel mutation produces an Emery-Dreifuss muscular dystrophy plus phenotype.

Authors:  Heather R Tiffin; Zandra A Jenkins; Mary J Gray; Sophia R Cameron-Christie; Jennifer Eaton; Salim Aftimos; David Markie; Stephen P Robertson
Journal:  Neurogenetics       Date:  2013-03-02       Impact factor: 2.660

9.  Skeletal muscle biopsy analysis in reducing body myopathy and other FHL1-related disorders.

Authors:  Edoardo Malfatti; Montse Olivé; Ana Lía Taratuto; Pascale Richard; Guy Brochier; Marc Bitoun; Lucie Gueneau; Pascal Laforêt; Tanya Stojkovic; Thierry Maisonobe; Soledad Monges; Fabiana Lubieniecki; Gabriel Vasquez; Nathalie Streichenberger; Emmanuelle Lacène; Maria Saccoliti; Bernard Prudhon; Marilena Alexianu; Dominique Figarella-Branger; Joachim Schessl; Carsten Bonnemann; Bruno Eymard; Michel Fardeau; Gisèle Bonne; Norma Beatriz Romero
Journal:  J Neuropathol Exp Neurol       Date:  2013-09       Impact factor: 3.685

10.  Exome Sequencing Identified a Splice Site Mutation in FHL1 that Causes Uruguay Syndrome, an X-Linked Disorder With Skeletal Muscle Hypertrophy and Premature Cardiac Death.

Authors:  Yuan Xue; Benedikt Schoser; Aliz R Rao; Roberto Quadrelli; Alicia Vaglio; Verena Rupp; Christine Beichler; Stanley F Nelson; Gudrun Schapacher-Tilp; Christian Windpassinger; William R Wilcox
Journal:  Circ Cardiovasc Genet       Date:  2016-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.